Marketing and Services Firm Signs Licensing Deal With Mexico City-Based Signufarma
WellTouch, PharmaCenra's premier compliance and persistency program has reached international waters. The program which touches physicians, patients and pharmaceutical companies in an innovative way via the telephone has revolutionized the industry. The licensing deal will allow the program to take an international focus.
Atlanta, GA (PRWEB) June 21, 2006
PharmaCentra, an Atlanta-based marketing and services firm that offers a full suite of customizable healthcare management programs for the pharmaceutical industry, recently signed a licensing agreement with Mexico City-based Signufarma that will bring WellTouchTM, PharmaCentra’s signature compliance and persistency program, to Mexico, Central America and South America. The deal allows Signufarma to integrate WellTouchTM into its own compliance and persistency programs, which are tailored for Latin American pharmaceutical companies, thereby adding new levels of service and advanced technology to the company’s initiatives for dealing with patient noncompliance.
“This is the perfect marriage between two companies that understand what today’s pharmaceutical companies need to help patients adhere to their doctors’ treatment recommendations and stay on track with their medication regimens,” says Barry Green, Executive Vice President and Chief Creative Officer of PharmaCentra. “We’re thrilled to partner with Signufarma, a true industry leader in Latin America, and provide the company with the resources it needs to enhance its already impressive efforts. In addition, this is a very exciting opportunity for us to watch pharmaceutical companies, physicians and patients in other parts of the world benefit from WellTouchTM.”
WellTouchTM is designed to open the lines of communication between everyone involved in the healthcare management process. As program participants, patients receive refill reminders and health tips through scheduled live and interactive voice response calls, physicians can monitor their patients’ progress by accessing online reports, and pharmaceutical companies can analyze patient drug use and determine how their brands are perceived.
Signufarma is one of a group of family-owned companies based in Mexico City that provide top-quality medical education to doctors and patients throughout Latin America. It offers a number of key services, including compliance programs for patients with chronic conditions, direct sales of specific drugs for compliance programs, direct marketing to physicians and drugstores, and data mining. According to Alberto Wicker, founder and Commercial Director of Signufarma, adding WellTouchTM to its repertoire will not only help it supply its clients with an unprecedented degree of service, but also boost its position in the marketplace.
“One of the things that will give us a competitive advantage in Mexico is WellTouch’s sophisticated technology,” he explains. “There are many companies trying to compete in the Mexican market; however, the lack of experience and technology is the most important downside for these contact centers. WellTouchTM is just what we need to provide our clients with the best possible compliance and persistency programs.”
To accommodate cultural differences and variations in how the healthcare system works in Mexico, Central America and South America, Signufarma will be able to modify the WellTouchTM program to fit its particular needs. The licensing agreement became effective when it was signed on Thursday, April 27, 2006.
PharmaCentra, located in Atlanta, offers versatile, customizable programs that are designed to help pharmaceutical companies provide comprehensive support to the physicians and patients who depend on their brands. From compliance and persistency to strategic sales and marketing, PharmaCentra’s programs and services represent the future of healthcare management, offering clients an array of integrated initiatives that allow them to effectively manage the flow of information between themselves, physicians and patients while increasing market share. For more information, contact Barry Green, Executive V. P. & CCO, at 770-395-0088, ext. 2030, or visit www. pharmacentra. com.
# # #
